Gerstoft J - Search Results

1

The origin and emergence of an HIV-1 epidemic: from introduction to endemicity.

Bruhn CA, Audelin AM, Helleberg M, Bjorn-Mortensen K, Obel N, Gerstoft J, Nielsen C, Melbye M, Medstrand P, Gilbert MT, Esbjörnsson J. Bruhn CA, et al. Among authors: gerstoft j. AIDS. 2014 Apr 24;28(7):1031-40. doi: 10.1097/QAD.0000000000000198. AIDS. 2014. PMID: 24451158

2

Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels.

Røge BT, Calbet JA, Møller K, Ullum H, Hendel HW, Gerstoft J, Pedersen BK. Røge BT, et al. Among authors: gerstoft j. AIDS. 2002 May 3;16(7):973-82. doi: 10.1097/00002030-200205030-00003. AIDS. 2002. PMID: 11953463

3

Cell-associated HIV DNA measured early during infection has prognostic value independent of serum HIV RNA measured concomitantly.

Katzenstein TL, Oliveri RS, Benfield T, Eugen-Olsen J, Nielsen C, Gerstoft J; Copenhagen AIDS Cohort Study Group. Katzenstein TL, et al. Among authors: gerstoft j. Scand J Infect Dis. 2002;34(7):529-33. doi: 10.1080/00365540110080845. Scand J Infect Dis. 2002. PMID: 12195879

4

Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients.

Ostrowski SR, Gerstoft J, Pedersen BK, Ullum H. Ostrowski SR, et al. Among authors: gerstoft j. AIDS. 2003 Mar 7;17(4):521-30. doi: 10.1097/00002030-200303070-00007. AIDS. 2003. PMID: 12598772

5

K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.

Røge BT, Katzenstein TL, Obel N, Nielsen H, Kirk O, Pedersen C, Mathiesen L, Lundgren J, Gerstoft J. Røge BT, et al. Among authors: gerstoft j. Antivir Ther. 2003 Apr;8(2):173-82. Antivir Ther. 2003. PMID: 12741630 Clinical Trial.

6

Low prevalence of hepatitis C virus antibodies in HIV-endemic area of Zimbabwe support sexual transmission as the major route of HIV transmission in Africa.

Kallestrup P, Zinyama R, Gomo E, Dickmeiss E, Platz P, Gerstoft J, Ullum H. Kallestrup P, et al. Among authors: gerstoft j. AIDS. 2003 Jun 13;17(9):1400-2. doi: 10.1097/00002030-200306130-00019. AIDS. 2003. PMID: 12799566 No abstract available.

7

Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

Gerstoft J, Kirk O, Obel N, Pedersen C, Mathiesen L, Nielsen H, Katzenstein TL, Lundgren JD. Gerstoft J, et al. AIDS. 2003 Sep 26;17(14):2045-52. doi: 10.1097/00002030-200309260-00005. AIDS. 2003. PMID: 14502007 Clinical Trial.

8

Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.

Jørgensen LB, Christensen MB, Gerstoft J, Mathiesen LR, Obel N, Pedersen C, Nielsen H, Nielsen C. Jørgensen LB, et al. Among authors: gerstoft j. Scand J Infect Dis. 2003;35(11-12):800-7. doi: 10.1080/00365540310016916. Scand J Infect Dis. 2003. PMID: 14723353

9

A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.

Kirk O, Lundgren JD, Pedersen C, Mathiesen LR, Nielsen H, Katzenstein TL, Obel N, Gerstoft J. Kirk O, et al. Among authors: gerstoft j. Antivir Ther. 2003 Dec;8(6):595-602. Antivir Ther. 2003. PMID: 14760893 Clinical Trial.

10

Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations.

Mathiesen S, Roge BT, Weis N, Lundgren JD, Obel N, Gerstoft J. Mathiesen S, et al. Among authors: gerstoft j. AIDS. 2004 Apr 30;18(7):1076-8. doi: 10.1097/00002030-200404300-00020. AIDS. 2004. PMID: 15096815 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

624 results

Search Page

Filters